Sernova (TSE:SVA) Stock Price Up 14.3% – Still a Buy?

Sernova Corp. (TSE:SVA)’s stock price rose 14.3% on Wednesday . The company traded as high as C$0.16 and last traded at C$0.16. Approximately 430,149 shares changed hands during trading, an increase of 276% from the average daily volume of 114,394 shares. The stock had previously closed at C$0.14.

Sernova Stock Up 17.9%

The company has a market cap of C$55.56 million, a P/E ratio of -3.30 and a beta of 0.44. The stock has a 50-day moving average of C$0.15 and a 200 day moving average of C$0.16. The company has a debt-to-equity ratio of -68.92, a current ratio of 0.02 and a quick ratio of 18.11.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.